|
Effect of Sedative and Anxiolytic Premedication on Children Experience After General Anesthesia
RECRUITINGPhase 3Sponsored by University Hospital, Montpellier
Actively Recruiting
PhasePhase 3
SponsorUniversity Hospital, Montpellier
Started2023-04-18
Est. completion2026-10-18
Eligibility
Age7 Years – 18 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05681572
Summary
Children undergoing general anesthesia for surgery commonly need sedative and anxiolytic premedication but little clinical evidence supports is benefit for children older than 7 years old. The aim of this prospective randomized clinical trial is to assess the impact of pharmacologic premedication on perioperative children experience.
Eligibility
Age: 7 Years – 18 YearsHealthy volunteers accepted
Inclusion Criteria: * Subject over 7 and under 18 years of age * Subjects who are scheduled for surgery * Subject who will be under general anesthesia * Subject able to complete a self-questionnaire in French Exclusion Criteria: * Subject who has already participated in the pediaPREM study * Subject with a treated anxiety disorder * Subject with cognitive disorders * Subject suffering from chronic pain (outside the operated area) * Subject with ADD (Attention Deficit Disorder) with or without hyperactivity, with or without treatment * Subject suffering from mental retardation * Subjects receiving psychotropic treatment * Subject whose intervention could reduce the ability to complete a self-questionnaire (neurosurgery etc.) * Subject with a contra-indication to midazolam and its excipients * Subject with a contra-indication to dexmedetomidine and its excipients * Subjects who need to receive intravenous alpha agonist in perioperative * Subjects requiring emergency intervention * Subjects requiring preoperative hypnosis * Subject who needs general anesthesia for diagnostic purposes (biopsy, etc...) * Subject having had a surgical intervention in the month preceding the inclusion. * Subject who will have an iterative surgical intervention within 15 days (removal of material, burns etc...) * Subjects who are scheduled for surgery as part of oncology management * Pregnant or breastfeeding woman * Subject whose two parents have not signed a written informed consent * Subjects who are not affiliated with or benefiting from a social security plan
Conditions2
AnesthesiaAnxiety
Interventions2
Related trials
- Determination of ED50 and ED95 With Clinical Efficacy of Intranasal Dexmedetomidine Combined With Esketamine for Preoperative Sedation in Pediatric General Anesthesia — Second Affiliated Hospital of Wenzhou Medical University
- Dexamethasone vs Dexmedetomidine for iPACK + ACB in TKA — Poznan University of Medical Sciences
- Dexmedetomidine Ropivacaine Versus Plain Ropivacaine in Bilateral Pectoralis Nerve (PECS) Block — Fayoum University
- Dexmedetomidinine in the Prevention of Postoperative Delirium in the Intensive Care Unit After Cardiac Surgery — University of Novi Sad
- Effect of Dexmedetomidine Supplementation to General Anaesthesia in Paediatric Transcatheter Closure of Atrial Septal Defect — Alexandria University
- Effect of Dexmedetomidine on Microsurgery Reconstruction in Cancer Patient — Dharmais National Cancer Center Hospital
- Intranasal Dexmedetomidine vs Oral Midazolam for Premedication in Pediatric Surgery — Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
- Mental Health After Dexmedetomidine for Electrical Storm — Ottawa Heart Institute Research Corporation
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhasePhase 3
SponsorUniversity Hospital, Montpellier
Started2023-04-18
Est. completion2026-10-18
Eligibility
Age7 Years – 18 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05681572